Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (71-80 of 343) with videos related to

Pageof 35
Sort By:
Hepatobiliary Surgery and Nutrition|May 16, 2017
Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Eugene J Koay, Bruno C Odisio, Milind Javle, et al.
The Oncologist|November 11, 2022
Palliative Rehabilitation in Acute Inpatient Rehabilitation: Prognostic Factors and Functional Outcomes in Patients with CancerJegy M Tennison, Arash Asher, David Hui, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2018
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma - Authors' replyKeri E Lunsford, Milind Javle, A Osama Gaber, et al.
Gastroenterology|April 27, 2010
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancerXiaoqun Dong, Milind Javle, Kenneth R Hess, et al.
Cancer|October 10, 2018
A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignanciesChristos Fountzilas, Milind Javle, Wei Tan, et al.
Annals of Surgical Oncology|December 6, 2006
COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survivalJason Foster, Jennifer Black, Charles LeVea, et al.
Nature Reviews. Disease Primers|October 27, 2022
Gallbladder cancerJuan C Roa, Patricia García, Vinay K Kapoor, et al.
Nature Reviews. Disease Primers|November 18, 2022
Publisher Correction: Gallbladder cancerJuan C Roa, Patricia García, Vinay K Kapoor, et al.
Hepato-Gastroenterology|August 22, 2007
Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinomaSikander Ailawadhi, Hiroki Nagase, Thaer Khoury, et al.
Annals of Surgical Oncology|November 15, 2006
Gallbladder cancer: Defining the indications for primary radical resection and radical re-resectionJason M Foster, Hisakazu Hoshi, John F Gibbs, et al.
Pageof 35

Showing results (71-80 of 343) with videos related to

Sort By:
Pageof 35
Hepatobiliary Surgery and Nutrition|May 16, 2017
Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?Eugene J Koay, Bruno C Odisio, Milind Javle, et al.
The Oncologist|November 11, 2022
Palliative Rehabilitation in Acute Inpatient Rehabilitation: Prognostic Factors and Functional Outcomes in Patients with CancerJegy M Tennison, Arash Asher, David Hui, et al.
The Lancet. Gastroenterology & Hepatology|July 27, 2018
Liver transplantation for locally advanced intrahepatic cholangiocarcinoma - Authors' replyKeri E Lunsford, Milind Javle, A Osama Gaber, et al.
Gastroenterology|April 27, 2010
Insulin-like growth factor axis gene polymorphisms and clinical outcomes in pancreatic cancerXiaoqun Dong, Milind Javle, Kenneth R Hess, et al.
Cancer|October 10, 2018
A phase 1, open-label, dose escalation study of intravenous paricalcitol in combination with gemcitabine in patients with advanced malignanciesChristos Fountzilas, Milind Javle, Wei Tan, et al.
Annals of Surgical Oncology|December 6, 2006
COX-2 expression in hepatocellular carcinoma is an initiation event; while EGF receptor expression with downstream pathway activation is a prognostic predictor of survivalJason Foster, Jennifer Black, Charles LeVea, et al.
Nature Reviews. Disease Primers|October 27, 2022
Gallbladder cancerJuan C Roa, Patricia García, Vinay K Kapoor, et al.
Nature Reviews. Disease Primers|November 18, 2022
Publisher Correction: Gallbladder cancerJuan C Roa, Patricia García, Vinay K Kapoor, et al.
Hepato-Gastroenterology|August 22, 2007
Intestinal trefoil factor (TFF-3) and extracellular signal-regulated kinase (ERK) in cholangiocarcinomaSikander Ailawadhi, Hiroki Nagase, Thaer Khoury, et al.
Annals of Surgical Oncology|November 15, 2006
Gallbladder cancer: Defining the indications for primary radical resection and radical re-resectionJason M Foster, Hisakazu Hoshi, John F Gibbs, et al.
Pageof 35